Cerus Corporation

CERS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 5.28%, EPS grew 50.3%, free cash flow fell 20.9% and total debt fell 23.5%, each against the same quarter a year earlier.

2.20 0.06 −2.65%
Market cap
$455.5M
P/E
0.0×
Fwd P/E
−81.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
4 4 5 3 5 3 4 4 5 5
P/S ratio
11.23 7.51 8.78 6.29 9.93 7.31 3.51 2.08 1.41 1.68
Altman Z-Score
(3.92) (7.17) (1.55) (4.12) 0.35 (0.54) (3.24) (4.87) (4.94) (4.00)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 52.87 0.00 33.35 354.35
Altman Z″-Score (non-manufacturers)
(19.22) (22.72) (12.89) (15.80) (10.58) (11.03) (14.03) (15.30) (14.46) (13.54)
Beneish M-Score
(2.82) (2.44) (3.05) (1.34) (2.66) (2.51) (2.52) (2.22) (3.35) (2.87)
P/Operating CF
(45.40) (38.39) (94.08) (71.77) (127.46) (954.51) (376.01) (25.65) 57.66 63.33
P/B ratio
7.63 9.89 7.90 10.34 10.93 13.62 9.63 7.29 5.00 6.04
Price to Tangible BV
7.91 10.39 8.06 10.61 11.07 13.84 9.82 7.47 5.11 6.17
EV/Sales
9.90 7.01 7.62 5.85 9.18 6.94 3.33 2.16 1.43 1.68
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(7.26) (6.89) (18.56) (8.38) (25.09) (32.62) (24.51) (9.34) 25.35 81.38
EV/FCF
(7.18) (6.84) (17.90) (7.37) (24.16) (31.77) 50.28 (8.44) 33.79 355.26
Quick Ratio
2.92 3.16 2.40 2.04 2.58 1.97 1.17 1.50 1.73 1.12
Current Ratio
3.50 3.89 2.79 2.55 3.06 2.38 1.45 2.14 2.39 1.73
Net Debt/EBITDA
0.88 0.55 1.64 0.65 1.55 1.31 1.04 (0.51) (0.30) (0.14)
Debt/Assets
18.72% 30.33% 18.27% 26.84% 21.73% 29.23% 32.01% 40.35% 41.89% 37.81%
Debt/Equity
0.34 0.77 0.35 0.78 0.46 0.81 1.02 1.49 1.48 1.29
Asset Turnover
0.32 0.51 0.58 0.57 0.59 0.70 0.83 0.90 1.01 1.11
Operating CF/Net income
0.85 0.86 0.54 0.92 0.70 0.62 0.60 1.15 (0.54) (0.31)
Capex/Depreciation
(0.31) (0.19) (0.79) (3.72) (0.52) (0.29) 12.77 (1.77) (1.53) (2.61)
Interest Coverage
(25.13) (19.04) (13.72) (10.92) (15.57) (9.94) (5.84) (3.58) (1.60) (1.04)
ROE
(82.47%) (125.27%) (93.25%) (100.65%) (74.42%) (57.41%) (55.49%) (61.45%) (37.92%) (25.65%)
ROA
(51.80%) (60.07%) (43.99%) (43.31%) (30.94%) (23.70%) (18.78%) (18.03%) (10.49%) (7.39%)
ROIC
(693.97%) (447.11%) 0.00% (262.55%) (199.05%) (119.11%) (58.82%) (27.87%) (14.67%) (8.22%)
Return on Tangible Assets
(89.61%) (87.95%) (56.24%) (76.88%) (43.59%) (45.03%) (66.78%) (43.82%) (21.89%) (18.88%)
Average Days of Receivables
63.83 88.29 42.00 65.71 67.62 57.50 66.73 69.37 53.99 47.42
Research and Development Expense of Revenue
79.75% 65.68% 55.97% 64.38% 56.38% 39.93% 34.04% 36.21% 29.26% 28.97%
Selling, General and Administrative Expense of Revenue
124.65% 102.51% 74.74% 70.60% 58.66% 50.96% 44.25% 40.43% 37.70% 34.61%
Intangible Assets out of Total Assets
0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
20.53% 18.23% 13.67% 14.20% 15.78% 14.78% 12.99% 10.85% 11.36% 9.78%
Graham Net Nets
0.11 0.08 0.10 0.03 0.06 0.03 0.03 0.00 0.03 0.04
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(14.32%) (15.73%) (8.68%) (12.32%) (5.20%) (4.55%) (6.68%) (9.58%) (7.08%) (3.89%)
Free Cash Flow Yield
(12.27%) (13.65%) (4.85%) (12.61%) (3.83%) (2.99%) 1.89% (12.27%) 3.00% 0.28%
Revenue per Share
0.39 0.47 0.58 0.67 0.70 0.93 1.07 1.04 1.09 1.23
Operating CF per Share
(0.53) (0.48) (0.24) (0.47) (0.25) (0.20) (0.15) (0.24) 0.06 0.03
Capex per Share
(0.01) 0.00 (0.01) (0.06) (0.01) (0.01) 0.22 (0.03) (0.02) (0.02)
Free Cash Flow per Share
(0.53) (0.49) (0.25) (0.53) (0.26) (0.20) 0.07 (0.26) 0.05 0.01
Cash per Share
0.70 0.56 0.89 0.61 0.81 0.76 0.58 0.37 0.44 0.43
Shareholders Equity per Share
0.57 0.36 0.64 0.41 0.63 0.50 0.39 0.30 0.31 0.34
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.57 0.36 0.64 0.41 0.63 0.50 0.39 0.30 0.31 0.34
Free Cash Flow
(54.09) (52.59) (32.39) (74.43) (43.43) (34.83) 12.49 (47.76) 8.52 1.11
Working Capital
67.22 66.77 94.22 77.77 123.46 108.55 53.09 76.92 88.41 73.58
Capital Expenditures
(0.56) (0.35) (1.14) (8.93) (1.61) (0.91) 38.10 (4.60) (2.84) (3.73)
Net Current Asset Value
48.42 30.59 67.96 19.63 65.82 35.22 20.61 0.14 8.00 17.49
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.01 0.02 0.10 0.01 0.01 (0.20) 0.02 0.01 0.02
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.61 0.85 0.18 0.16 0.22 0.26 0.27 0.30 0.26 0.15
Cash ROIC
(36.35%) (40.63%) (13.96%) (39.76%) (15.21%) (12.25%) 5.19% (23.99%) 3.85% 0.48%
Accounts Receivable Turnover
6.20 5.32 7.19 7.32 6.01 6.89 6.32 5.34 6.17 7.77
Accounts Payable Turnover
2.94 2.30 2.14 1.64 1.77 2.12 2.18 2.46 3.55 3.78
Inventory Turnover
1.74 1.67 2.26 2.02 1.93 2.54 2.69 2.03 2.07 1.99
Average Days of Payables
154.43 177.78 214.55 242.30 214.73 204.76 160.71 124.38 98.07 108.93
Days of Inventory on Hand
225.37 234.20 156.22 212.87 206.23 154.07 141.23 207.98 172.45 218.20
Average Receivables
6.33 9.64 10.58 12.82 19.02 23.15 29.78 34.96 32.64 30.08
Average Payables
6.90 9.78 14.78 20.39 23.20 29.91 34.31 28.42 22.77 24.85
Average Inventory
11.67 13.49 14.00 16.51 21.37 25.02 27.90 34.44 39.01 47.13
Average Assets
121.44 100.86 130.85 164.50 193.48 229.46 227.80 207.92 199.33 211.39
Average Common Equity
76.28 48.36 61.73 70.79 80.43 94.71 77.09 61.00 55.17 60.93

Fold the line items

Columns are period end dates